Les Laboratoires Servier SAS - Company Profile
Powered by
All the data and insights you need on Les Laboratoires Servier SAS in one report.
- Save hours of research time and resources with
our up-to-date Les Laboratoires Servier SAS Strategy Report
- Understand Les Laboratoires Servier SAS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Les Laboratoires Servier SAS (Servier) manufactures and sells drugs to help treat various diseases. The company’s established position, coupled with focused R&D activities and generic medicine offerings, is set to drive future growth. Overdependence on Asia and Oceania could have an effect on its business operations. Market Potential of Duchenne Muscular Dystrophy (DMD) and strategic agreements could provide new growth avenues to the company. However, increasing competitive pressures, changing government regulations, and uncertain R&D outcomes can be a setback for the company's continued growth.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer